The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PERSPECTIVES

Transcatheter aortic valve implantation: don’t forget the coronary arteries!

EuroIntervention 2018;14:147-149. DOI: 10.4244/EIJV14I2A24

Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark


Transcatheter aortic valve implantation (TAVI) was introduced as a less invasive alternative to surgical aortic valve replacement (SAVR) in patients with severe symptomatic aortic stenosis. After initially addressing patients at extreme or high surgical risk, TAVI has been shown to be non-inferior to SAVR with regard to mortality and disabling stroke in patients at intermediate surgical risk. These encouraging findings have led to trials comparing TAVI and SAVR in low-risk patients (NCT02675114, NCT02701283) and younger patients (NCT02825134). However, expanding TAVI to these patients is related with a number of potential issues, e.g., the higher prevalence of bicuspid aortic ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Impact of left atrial appendage morphology on indication and procedural outcome after interventional occlusion: results from the prospective multicentre German LAARGE registry